Suchergebnisse
Wall Street Analysts Predict a 55.04% Upside in Immunovant (IMVT): Here's What You Should Know
Shares of Immunovant, Inc. (IMVT) have gained 0.4% over the past four weeks to close the last trading session at $26, but there could still be a solid upside left in the stock if short-term price
IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus
Immunovant, Inc. (IMVT) reported third-quarter fiscal 2026 net loss of 61 cents per share, narrower than the Zacks Consensus Estimate of a loss of 72 cents. The company had reported a loss of 76